Home > Insider Trading > Filing (0000899243-18-021742)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413822	Anastasios Gianakakos	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-08-06	3,000	$1.51	77,949	No	4	M	Direct
Common Stock	Disposition	2018-08-06	800	$56.98	77,149	No	4	S	Direct
Common Stock	Disposition	2018-08-06	2,200	$57.65	74,949	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-08-06	3,000	$0.00	3,000	$1.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
114,254		2025-06-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	85,973	Indirect	By Reporting Person's Trust 2
Common Stock	500,000	Indirect	By Reporting Person's Trust 3
Common Stock	12,200	Indirect	By Trust 1
Common Stock	12,200	Indirect	By Trust 2
Common Stock	12,200	Indirect	By Trust 3

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $56.30 to $57.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of the shares sold ranging from $57.40 to $58.05 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date.